Applied Proteomics

Applied Proteomics

Based: San Diego
Raised: $22.5 million
Investors: Domain Associates and Vulcan Capital

The scoop: Applied Proteomics got 2012 off to a stylish start, raising fresh cash, moving from Glendale to San Diego and bringing in a new CEO, Peter Klemm, the former CEO of Lexington, MA-based Predictive Biosciences. The diagnostic test manufacturer was also planning some new hires in the new year.

Applied Proteomics
Read more on

Suggested Articles

Cour unveiled phase 2 data showing that its treatment cut levels of pro-inflammatory cytokines and protected the gut in patients with celiac disease.

Three years after Bayer and gene-editing biotech CRISPR Therapeutics joined forces to launch and run Casebia Therapeutics.

Fresh off Tilos Therapeutics’ $773 million sale to Merck, Barbara Fox is taking the helm of another Cambridge-based company: Rheos Medicines.